Who Owns FRX?

FENNEC PHARMACEUTICALS INC — Institutional Ownership & 13F Holdings

$0.00

+0.00 (+0.00%)

Market Cap

Shares Outstanding

Institutional Holders

68

Total Inst. Value

$81.8M

% of Float Held

QoQ Holder Change

+15

Institutional data as of Q1 2025

New Positions

11

Closed Positions

6

Increased

19

Decreased

21

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Southpoint Capital Advisors LP$24.8M4,077,214
2Solas Capital Management, LLC$13.7M2,250,919
3Rosalind Advisors, Inc.$10.9M1,782,844
4BlackRock, Inc.$7.6M1,250,288
5VANGUARD GROUP INC$5.9M964,620
6HARBERT FUND ADVISORS, INC.$2.8M466,869
7AIGH Capital Management LLCNew$2.2M361,005
8STATE STREET CORP$2.1M338,133
9GEODE CAPITAL MANAGEMENT, LLC$1.9M311,332
10MORGAN STANLEY$1.8M296,613

Biggest Buyers & Sellers This Quarter

Top Buyers

Frequently Asked Questions

How many institutional investors hold FRX?

As of Q1 2025, 68 institutional investors report holding FRX (FENNEC PHARMACEUTICALS INC) in their 13F filings.

Which hedge fund owns the most FRX?

The largest institutional holder of FRX is Southpoint Capital Advisors LP with $24.8M in shares.

Are institutions buying or selling FRX?

This quarter, 11 institutions opened new positions in FRX and 6 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.